中国P站

Oxidative stress; Mitochondrial dysfunction; Inflammation; Aging; Neurodegenerative diseases; Cancer; Cardiovascular diseases; Metabolic syndrome; Chronic kidney disease; Gut microbiota

Introduction

The intricate relationship between cellular processes and overall health is a cornerstone of modern biology. A recurring theme in this landscape is oxidative stress, a state characterized by an imbalance between the production of reactive oxygen species (ROS) and the body's ability to detoxify these harmful byproducts or repair the resulting damage. This phenomenon is implicated in the etiology and progression of a vast spectrum of diseases and in the fundamental process of aging. Specifically, research delves into the critical role of mitochondrial dysfunction and subsequent oxidative stress in the aging process and various age-related diseases. Disrupted mitochondrial function leads to increased reactive oxygen species production, significantly impacting cellular health and contributing to pathology. Understanding these mechanisms is crucial for developing interventions against aging and its associated conditions [1].

This exploration continues by examining the intricate connection between oxidative stress and inflammation in the progression of neurodegenerative diseases. These two pathways form a vicious cycle, contributing to neuronal damage and disease progression. Targeting both pathways simultaneously could offer a more effective therapeutic strategy for conditions like Alzheimer's and Parkinson's [2].

Moreover, the dual role of oxidative stress in cancer is noteworthy, with its potential to cause DNA damage leading to tumor initiation, yet also its exploitation in cancer therapies to induce cell death. The complex interplay of DNA damage response mechanisms in cancer progression and treatment resistance offers insights into targeted therapeutic strategies [3].

The fundamental role of oxidative stress in the pathogenesis of various cardiovascular diseases, including atherosclerosis, hypertension, and heart failure, is also a significant area of focus. An imbalance between pro-oxidants and antioxidants contributes to endothelial dysfunction and myocardial damage, proposing several antioxidant strategies as potential therapeutic avenues to mitigate these effects [4].

Moving to metabolic health, oxidative stress is centrally involved in the development and progression of metabolic syndrome, linking it to insulin resistance, obesity, and dyslipidemia. Evaluating various therapeutic strategies, including lifestyle interventions and pharmacological agents, aims to mitigate oxidative damage and improve metabolic health outcomes [5].

Oxidative stress significantly contributes to skin aging. Reactive oxygen species damage cellular components like collagen and elastin, leading to visible signs of aging. Potential antioxidant interventions, from topical applications to dietary supplements, are explored to combat these deleterious effects [6].

The fascinating interplay between gut microbiota and host health is also gaining attention, specifically how metabolites produced by gut bacteria influence oxidative stress and inflammation. Modulating the gut microbiome through diet or probiotics represents a strategic approach to mitigate chronic diseases associated with these fundamental cellular processes [7].

The significant role of oxidative stress in the progression of chronic kidney disease (CKD) is also detailed, explaining how an imbalance of pro-oxidants and antioxidants contributes to renal damage and fibrosis. Emerging therapeutic strategies aimed at counteracting oxidative damage in CKD patients offer hope for improved management [8].

Additionally, the crucial link between oxidative stress and mitochondrial dysfunction in the pathogenesis of diabetes mellitus is highlighted. Hyperglycemia-induced overproduction of reactive oxygen species damages cellular components, impairs insulin signaling, and contributes significantly to the long-term complications of diabetes, such as neuropathy and retinopathy [9].

Finally, the complex role of oxidative stress in brain aging and age-related neurodegenerative diseases is reviewed, detailing molecular mechanisms by which reactive oxygen species accumulate in the brain, leading to neuronal damage and cognitive decline. This includes discussions on potential antioxidant interventions and lifestyle modifications that could mitigate these effects [10].

Description

Oxidative stress, a critical imbalance between the production of reactive oxygen species (ROS) and antioxidant defenses, underlies a broad spectrum of human pathologies and the aging process. It significantly impacts cellular health by damaging vital components like DNA, proteins, and lipids. For example, mitochondrial dysfunction, a key contributor to increased ROS production, is directly linked to the acceleration of aging and the development of various age-related diseases. This fundamental process disrupts normal cellular function, setting the stage for pathology and highlighting the need for interventions that target mitochondrial health and redox balance [1]. Similarly, in the context of brain aging, the accumulation of ROS leads to neuronal damage and cognitive decline, making understanding these molecular mechanisms crucial for developing antioxidant interventions and lifestyle modifications [10]. The visible signs of aging, particularly in the skin, are also driven by oxidative stress, where ROS degrade collagen and elastin, pointing towards topical and dietary antioxidant strategies [6].

The interplay between oxidative stress and inflammation forms a vicious cycle central to the progression of neurodegenerative diseases. This dual-pathway mechanism contributes significantly to neuronal damage, suggesting that therapies targeting both oxidative stress and inflammatory responses simultaneously could be more effective for conditions such as Alzheimer's and Parkinson's [2]. Beyond the nervous system, this insidious connection extends to metabolic health. Oxidative stress is intimately involved in metabolic syndrome, fostering insulin resistance, obesity, and dyslipidemia. Comprehensive reviews evaluate various therapeutic strategies, including lifestyle changes and pharmacological agents, to mitigate this damage and improve overall metabolic outcomes [5]. Furthermore, in diabetes mellitus, hyperglycemia-induced overproduction of ROS exacerbates oxidative stress and mitochondrial dysfunction, impairing insulin signaling and contributing to severe long-term complications like neuropathy and retinopathy [9].

Cardiovascular diseases, including atherosclerosis, hypertension, and heart failure, are also profoundly influenced by oxidative stress. An imbalance of pro-oxidants and antioxidants leads to endothelial dysfunction and myocardial damage. Research explores various antioxidant strategies as promising therapeutic avenues to counteract these detrimental effects and protect cardiovascular health [4]. In a similar vein, chronic kidney disease (CKD) progression is significantly driven by oxidative stress, where the imbalance promotes renal damage and fibrosis. Emerging therapeutic approaches focus on counteracting this oxidative damage, offering new hope for CKD patient management and improved quality of life [8].

Interestingly, the role of oxidative stress in cancer is complex and dual-natured. While it can cause DNA damage, leading to tumor initiation and progression, it is also exploited in cancer therapies to induce cell death. Understanding the DNA damage response mechanisms is vital for navigating cancer progression and overcoming treatment resistance, paving the way for targeted therapeutic strategies [3]. Moreover, the gut microbiota exerts a profound influence on host health, with its metabolites affecting systemic oxidative stress and inflammation. Modulating the gut microbiome through diet or probiotics presents a strategic and innovative approach to mitigate chronic diseases associated with these fundamental cellular processes, highlighting a broader, holistic view of health interventions [7]. Collectively, these findings underscore the pervasive nature of oxidative stress and the critical importance of developing multifaceted approaches to maintain cellular integrity and combat disease.

Conclusion

The provided research highlights the critical and multifaceted role of oxidative stress in a wide array of human diseases and the aging process. It becomes clear that an imbalance between reactive oxygen species production and antioxidant defenses is a central mechanism driving pathology across different physiological systems. For instance, mitochondrial dysfunction exacerbates oxidative stress, accelerating aging and contributing to age-related conditions, while also playing a significant part in the pathogenesis of diabetes mellitus. Oxidative stress is intricately linked with inflammation, forming a detrimental cycle that fuels neurodegenerative diseases like Alzheimer's and Parkinson's. In cancer, this stress presents a dual role, initiating DNA damage that can lead to tumor development, yet also being exploited in therapies to induce cell death. Furthermore, oxidative stress is a fundamental driver in cardiovascular diseases, causing endothelial dysfunction and myocardial damage, and is central to the development and progression of metabolic syndrome, influencing insulin resistance, obesity, and dyslipidemia. Its impact extends to chronic kidney disease, where it promotes renal damage, and to skin aging, where it degrades essential components like collagen. The gut microbiota also emerges as a crucial modulator, with its metabolites influencing host oxidative stress and inflammation, offering novel therapeutic avenues. The collective understanding points towards antioxidant strategies, lifestyle interventions, and targeted molecular approaches as promising ways to combat these pervasive health challenges.

References

1.    
2. Lidia SG, Maria VC, Mihaela DC (2023) .Cells 12:2289.        

   , ,

3.    
4. Yuxing L, Yanyan L, Yanhong H (2022) .Antioxidants (Basel) 11:2246.        

   , ,

5.    
6. Yunlong M, Zifan Z, Jing H (2024) .J Clin Transl Res 10:29-45.        

   , ,

7.    
8. Jianping L, Li Z, Min G (2023) .Front Cardiovasc Med 10:1111108.        

   , ,

9.    
10. Jian-Rong W, Jian-Jun L, Jing-Yu W (2022) .Antioxidants (Basel) 11:2269.        

    , ,

11.    
12. Katarzyna W, Paulina G, Joanna S (2021) .Antioxidants (Basel) 10:1779.        

    , ,

13.    
14. Wen L, Xiaojian W, Li C (2020) .Front Immunol 11:606214.        

    , ,

15.    
16. Jian L, Mingkai C, Yuying S (2023) .Front Pharmacol 14:1184920.        

    , ,

17.    
18. Jiaqi S, Yuan Y, Wenjuan Z (2022) .Front Endocrinol (Lausanne) 13:902422.        

    , ,

19.    
20. Monica N, Giada S, Carlotta C (2021) .Antioxidants (Basel) 10:1530.        

    , ,